Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
32.8M
-
Shares change
-
+796K
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$24.1M
-
Put/Call ratio
-
2
-
Number of buys
-
106
-
Number of sells
-
-93
-
Price
-
$36.35
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q1 2016
232 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q1 2016.
Emergent BioSolutions Inc. - Common Stock (EBS) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.8M shares
of 54.5M outstanding shares and own 60.26% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.19M shares), DIMENSIONAL FUND ADVISORS LP (2.06M shares), BlackRock Fund Advisors (1.89M shares), ACADIAN ASSET MANAGEMENT LLC (1.59M shares), Bank of New York Mellon Corp (1.35M shares), RENAISSANCE TECHNOLOGIES LLC (1.11M shares), STATE STREET CORP (1.1M shares), D. E. Shaw & Co., Inc. (892K shares), BlackRock Institutional Trust Company, N.A. (847K shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (831K shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.